{'fraction_non_alphanumeric': 0.020872865275142316, 'fraction_numerical': 0.0, 'mean_word_length': 5.6, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Safe prescribing of direct oral anticoagulants for non‐valvular AF

The use of direct oral anticoagulants (DOACs) is becoming increasingly common in primary care. While this group of drugs requires less intensive monitoring than warfarin, safe prescribing is still necessary to achieve optimum therapeutic effect and minimise adverse effects. This article discusses the key principles of safe DOAC prescribing for non‐valvular atrial fibrillation (NVAF), and the systems that general practices can put in place to achieve this.